Physician profile
Alson Greiner
NPI 1588694350
$191.64
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $26.70 · 2021: $18.33.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $56.57 | 2019 | |
| Sunovion Pharmaceuticals INC. | $31.65 | 2019 | |
| Novartis Pharmaceuticals Corporation | $28.69 | 2019 | |
| Boston Scientific Corporation | $18.33 | 2021 | |
| Nevro Corp. | $16.29 | 2019 | |
| Mdd US Operations, LLC | $14.16 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.41 | 2019 | |
| Indivior INC. | $12.54 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alson Greiner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.